Assessing user fees under the biosimilar user fee amendments of 2017
- Collection:
- Health Policy and Services Research
- Series Title(s):
- Guidance for industry
- Contributor(s):
- United States. Department of Health and Human Services, issuing body. United States. Food and Drug Administration, issuing body. Center for Biologics Evaluation and Research (U.S.), issuing body. Center for Drug Evaluation and Research (U.S.), issuing body.
- Publication:
- Silver Spring, MD : Center for Drug Evaluation and Research, June 2018
- Language(s):
- English
- Format:
- Text
- Subject(s):
- Biosimilar Pharmaceuticals -- economics Fees and Charges Investigational New Drug Application -- economics Drug Evaluation -- economics Parenteral Nutrition Solutions -- economics Humans United States United States. Department of Health and Human Services. United States. Food and Drug Administration.
- Genre(s):
- Guideline Technical Report
- Copyright:
- The National Library of Medicine believes this item to be in the public domain. (More information)
- Extent:
- 1 online resource (1 PDF file (17 pages)).
- NLM Unique ID:
- 101734364 (See catalog record)
- Permanent Link:
- http://resource.nlm.nih.gov/101734364